Functional Technologies Corp. develops and commercializes proprietary yeast-based solutions for the food, beverage, and healthcare industries. The company's platform enhances the performance of innate yeast functions, and prevents the formation of naturally occurring toxins and contaminants that affect final product quality and are classified as probable human carcinogens. Its technologies include yeasts that prevent and reduce the formation of foul-smelling hydrogen sulphide and acrylamide that are found in consumed items, such as fermented food products and alcoholic beverages, and baked and fried foods. The company is also developing various early-stage research programs, such as biologically active molecules derived from its proprietary algae-based technology, with encompasses vaccines, anti-microbial peptides, and other algae-based health products, as well as a yeast-based approach for the treatment of malaria. Functional Technologies Corp. offers its products primarily in North America, South America, and Europe. The company was formerly known as First Venture Technologies Corp. and changed its name to Functional Technologies Corp. in 2008. Functional Technologies Corp. is headquartered in Vancouver, Canada. As of April 25, 2013, Functional Technologies Corp. is in liquidation.